Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Optimal Treatment on Hepatocellular Carcinoma (HCC) With Cirrhotic Portal Hypertension

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2015 by Sun Yat-sen University
Sponsor:
Information provided by (Responsible Party):
Yunfei Yuan, Sun Yat-sen University
ClinicalTrials.gov Identifier:
NCT01642446
First received: July 12, 2012
Last updated: November 17, 2015
Last verified: November 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2022
  Estimated Primary Completion Date: June 2022 (Final data collection date for primary outcome measure)